Rallybio CorporationRLYBNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank33
3Y CAGR-38.9%
5Y CAGR-9.3%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
-38.9%/yr
Annual compound
5Y CAGR
-9.3%/yr
Recent deceleration
Percentile
P33
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
TTM$38000.00-
2024$0.00-100.0%
2023$150000.00-10.2%
2022$167000.00+53.2%
2021$109000.00+75.7%
2020$62030.00+135.5%
2019$26344.00-